Navigation Links
ImaginAb Expands Scientific Advisory Board
Date:11/25/2013

itemprop="name">Jonathan Spicehandler M.D. Professor of Neuro-Oncology Research at Duke University. The addition of Dr. Zalutsky marks the beginning of a more formal foray into radioimmunoconjugates for therapeutic purposes, including the potential of using alpha-emitting isotopes in conjunction with ImaginAb's minibody platform.

The addition of Drs. Wittrup, Senter and Zalutsky also marks the formal retirement from ImaginAb's SAB of Dr. Steven Larson, the Donna and Benjamin M. Rosen Chair in Radiology at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Dan Shochat, formerly Vice President of Development at KaloBios Pharmaceuticals Inc. has joined the management of ImaginAb on a part-time basis as Vice President of Manufacturing and also steps down from ImaginAb's SAB.

Drs. Wittrup, Senter and Zalutsky join founding ImaginAb SAB members Dr. Sanjiv "Sam" Gambhir, Virginia and D.K. Ludwig Professor in Cancer Research, Director Stanford Molecular Imaging Program and Dr. James D. Marks, Professor, Departments of Anesthesia and Pharmaceutical Chemistry, UCSF.

"We welcome these new members to our SAB, but also warmly thank Dr. Larson and Dr. Shochat for their outstanding service to our SAB during the start-up phase of ImaginAb – their advice and continuous challenge of our scientific and commercial assumptions was invaluable," noted Dr. Christian Behrenbruch, CEO of ImaginAb. "We'd particularly like to thank Dr. Larson who has been a driving force in the development of our PSMA minibody technology, currently under clinical investigation at MSKCC."

About ImaginAb

ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging.  The company's proprietary antibody fragment platform yields actionable molecular information to guide
'/>"/>

SOURCE ImaginAb, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Edison expands international biotechnology presence with launch of full coverage of Athersys
2. VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
3. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
4. ACell Expands Indiana Manufacturing Facility to Support Growth
5. BSMA Expands Advisory Board to Advance BIOTECH SUPPLY CHAIN
6. Annai Systems Expands Access to GTFuse for Rapid and Cost-effective Use of Sequencing Data
7. Digiscribe Expands Document Scanning Services
8. MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
9. PTC Therapeutics Expands Management Team
10. Protagonist Therapeutics Expands Series B Financing to $18 Million with Addition of $4 Million from Pharmstandard
11. Vince & Associates, Brad Vince Expands Early Phase Gastrointestinal Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Pipette.com announces their Holiday in the ... their #HolidayInTheLab pictures for a chance to win pipette-themed ... those struggling to think of a holiday gift for ... Lab Contest provides the ideal holiday presents. The #HolidayInTheLab ... pictures of their chemistree, holiday sweaters, as well as ...
(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 22, 2014  ( www.competitivehealth.com ) — Competitive Health ... bill review and advocacy service, has signed an agreement ... Savings discount health services marketplace. 63% of ... than they expected to pay. As part of an ... WellCard Savings is pleased to offer medical bill review ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... Pa. and WEYBRIDGE, England, Dec. 6, 2010 ... Idis, the global leader in developing long-term strategic ... two companies have partnered to facilitate access to ... (NPP).  ViroPharma,s NPP, developed and managed by Idis, ...
... ANGELES, Dec. 6, 2010 Todd Hutchings has assumed ... Practice Group.  Peter Levin, who led the practice, will ... recruiting CEOs and C-Level executives. In his ... core client relationships, working with boards and providing the ...
... Dec. 6, 2010 Cell Therapeutics, Inc. ("the Company") ... of study ("EOS") follow up results from the Company,s ... basis for the Company,s recent Marketing Authorization Application (the ... ("EMA"). The end-of-study results showed continued improvement ...
Cached Biology Technology:ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program 2ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program 3Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group 2New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 2New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 3New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 4New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 5New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 6
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... , November 18, 2014 ... Systems Market by Systems (Video, RFID, Access Control, Intrusion ... Factories, Hotels, Banks, Government), Component Service Geography - Global ... Systems Market is projected to be around $25 Billion ... by 2020, growing at a CAGR of 8.69%. ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... Georgia Institute of Technology have developed a strategy to ... prevent the pollutant from finding its way from a ... a zero emission car, and a transportation system completely ... dioxide emissions from large-scale sources such as power plants ...
... developing is a goal of Raphael Kopan, Ph.D., professor ... School of Medicine. The moss plant (Physcomitrella patens) ... Spencer T. Olin Professor and chair of the WUSTL ... toward that goal. Heres how. The gene ...
... in the media, and recently, in our daily lives, ... is affecting global climate change. Studying just how carbon ... one Northwestern University professor is doing his part by ... associate professor of civil and environmental engineering in the ...
Cached Biology News:Carbon capture strategy could lead to emission-free cars 2Carbon capture strategy could lead to emission-free cars 3Carbon capture strategy could lead to emission-free cars 4Moss protein plays role in Alzheimer's disease 2Moss protein plays role in Alzheimer's disease 3Moss protein plays role in Alzheimer's disease 4Studying rivers for clues to global carbon cycle 2Studying rivers for clues to global carbon cycle 3
Rabbit polyclonal to Xanthine Oxidase (HRP) ( Abpromise for all tested applications). Antigen: Xanthine Oxidase (from Bovine Buttermilk) Entrez Gene ID: 7498 Swiss Protein ID: P47989...
Phospho- (Ser) 14-3-3 Binding Motif (4E2) Mouse mAb...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
GBL Antibody...
Biology Products: